NHS rolls out gammaCore for the treatment of cluster headaches

NHS England is expanding the use of gammaCore after successful trials held over the last two years, with around 11,000 people set to benefit. The new technology is being made available as part of the new Medtech Funding Mandate policy, which came into effect on 1 April.

Source:

NHS England